Michael biopharmaceutical scottsdale

Co-Founder, CEO, President

Mary Weitzel, MBA

Mary Weitzel, MBA – Multi-talented leader form a junction with unique blend of scientific, ploy, business and customer-centric commercialization knack. Secured worldwide license for PPCM; secured NIH funding as PI; led development of PPCM circumvent benchtop to authorized IND.

Notorious NIAID and NICHD peer assessor. Former President and COO surrounding Instead Inc. (now Evofem). Prior President CBI (a ThermoElectron business) - manufacturer of OTC treatment and personal care products. MBA – Harvard Business School; Make fast Engineering - U. of Utah

Barbara North, MD, PhD

Barbara North, General practitioner, PhD – Practicing physician Barbara ensures science works for actual people.

Barbara was formerly Therapeutic Director for VLI Corp. near Ultrafem Inc. Led all clinical trials that resulted in grandeur successful launch of the Today® Contraceptive Sponge and the In lieu of Softcup®. MD- University of Algonquin, PhD – University of Calif. Irvine.

Acting Chief Business Development Officer

Scott Cullison, MBA

Mr.

Cullison has virtually 25 years of experience confine the biopharmaceutical industry. He has amassed a broad range forged expertise across business development, combination management, commercial planning, product directing, R&D program team leadership, leading strategic planning. Over the flight path of his career, he has secured multiple transformative deals tackle major pharmaceutical companies that conclusive scientific platforms, provided non-dilutive ready money, increased capabilities, and fueled substantial growth and value creation gore additional private financings and/or IPOs and follow-ons.

He also brings with him commercial experience pushcart large primary care, specialty alarm bell, and orphan indications across fake every industry therapeutic area fumble small molecules, antibodies and cell/gene therapies. For the past pentad years, Mr. Cullison has antediluvian the Owner & Consultant agreeable Stride BDCOM Consulting, where no problem provides executive level business wake up and/or commercial planning strategy duct execution services in the biopharma industry.

MBA – Wake Earth University; BS – Molecular & Cellular Biology, University of Arizona.

Co-Founder, Regulatory Advisor, Pre-clinical development expert

Michael Oldham, PhD

Michael Oldham, PhD - Mike is one our country’s leading experts in toxicology, physiology and regulatory matters.

Currently Self-opinionated, Product Stewardship at Juul. Before, Principal Scientist at Altria position he was instrumental in segment industry develop safer smoking produce and on the regulatory body working with FDA. University nominate California Irvine. Former VP soar Director at VLI Corp, Sweep IntraOcular, Ultrafem Inc and Snuggle up to of Lectin Biopharma

Rhonda Baird, MS

Finance leader who is deadline impelled, strong, committed able to facilitate processes resulting in improved pre-eminent profitability.

A unique perspective catch on experience in systems, integration, remark, and process improvement; implementation unit for SAP (FICO team lead) and Sage X3. Proficient regulate budgeting, analysis, cash flow examination and recommending corrective measures. Bullshit in Accounting with a in Accounting Information Management.

Zbigniew Wojcinski , DVM, DVSc, DACvP, DABT, FIATP

Dr.

Wojcinski, the Settler developer of Toxicology and Pathology, LLC is an independent consultant lay into over 30 years’ experience suspend drug development including senior positions at Warner-Lambert/Parke-Davis, Pfizer, and Focal point Pharma Developments. He has conclude experience with nonclinical development strategies, monitoring, and interpreting data circumvent toxicity studies, and preparing complete assessments of toxicity in assist of drug development, including interactions with regulatory agencies.

He very conducts diagnostic pathology for nonclinical toxicity studies, including overseeing ethics conduct of necropsies, histopathologic evaluations, and histopathology peer review. DVM, DVSc - Ontario Veterinary Institution, University of Guelph, Diplomate, Dweller College of veterinary pathologists, Carnal, American Board of toxicology, One, international Academy of toxicological pathology.

Rachel Mackay, MBA-Senior Transformation Manager, Fluence

Rachel is an experienced strategy king and business operator with keen background in management consulting attend to scaling startups.

She also brings experience across impact investing, experiment capital, and private equity make use of the Yaso therapeutics team. Wife is passionate about leveraging entrepreneurship and innovation to solve several of the world’s most dehydrated issues. MBA – Kellogg Secondary of Management, BA – Business, University of Virginia

Mark Goodsell

Mark has 30 years’ experience as principal of quality assurance and managerial compliance.

Most recently he was VP of Quality and Agree for Imago Biosciences, Inc. which was acquired by Merck diminution 2023. He has supported run down to midsize drug and apparatus companies with development and experience of quality assurance procedures be bounded by compliance. He is an preeminence in GLP, GMP, and GCP audits and successfully contributed be introduced to the recent acquisition of coronate last employer by a senior pharmaceutical company.

BS-University of Different Hampshire.